查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824452

2025年罕见疾病诊断全球市场报告

Rare Disease Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年罕见疾病诊断市场将快速成长，到2029年将达到560.8亿美元，年复合成长率（CAGR）为10.1%。预测期内的增长可归因于罕见患者病率的上升、政府倡议的增多、医院和诊断实验室数量的增加、血液病数量的增加以及医疗保健基础设施的完善。预测期内的主要趋势包括基因检测技术的进步、全基因定序和次世代定序(NGS) 的普及、对研究倡议的大量投资以及策略合作。

未来五年10.1%的成长预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加美国供应商的负担，因为这会增加来自英国和韩国的次世代定序盒和基于CRISPR的检测套件的成本，从而加剧诊断延误并提高基因检测成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税上涨的影响也可能更加广泛。

由于罕见疾病的盛行率不断上升，罕见疾病诊断市场可望成长。罕见疾病的特征是人口盛行率低，需要专门的诊断才能有效管理、确定潜在的治疗方法并避免不必要的治疗。例如，根据国际骨质疏鬆症基金会 (IOF) 于 2021 年 2 月发布的数据，全球有超过 3 亿人患有罕见疾病，占全球人口的 3.5% 至 5.9%。此外，HealthMatch 在 2022 年 11 月报告称，美国和欧洲约有 150 种罕见肾病，每 10 万人中有 60 至 80 人患病。因此，罕见疾病发生率的上升正在推动罕见疾病诊断市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球罕见疾病诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球罕见疾病诊断市场：成长率分析
  • 全球罕见疾病诊断市场表现：规模与成长，2019-2024
  • 全球罕见疾病诊断市场预测：2024-2029年及2034年规模与成长
  • 全球罕见疾病诊断：总目标市场（TAM）

第六章 市场细分

  • 全球罕见疾病诊断市场：按检测类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 基因检测
  • 常见的实验室检查
  • 影像检查
  • 全球罕见疾病诊断市场：依技术、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 毛细管定序
  • 全基因组定序
  • 全EXOME定序
  • 微阵列
  • 全球罕见疾病诊断市场：依样本类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）样本
  • 口腔拭子样本
  • 血
  • 唾液
  • 全球罕见疾病诊断市场：依疾病类型、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 消化系统疾病
  • 内分泌和代谢紊乱
  • 血液疾病和肿瘤疾病
  • 皮肤病
  • 心血管疾病
  • 神经系统疾病
  • 全球罕见疾病诊断市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院检查室
  • 诊断实验室
  • 基因检测实验室
  • 癌症研究所
  • 全球罕见疾病诊断市场：依基因检测细分（依检测类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全基因组序列分析
  • 标靶基因面板
  • EXOME定序
  • 职业测试
  • 全球罕见疾病诊断市场：细分市场、一般临床检测（依检测类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血液检查
  • 生化检测
  • 尿液检查
  • 细胞遗传学检测
  • 全球罕见疾病诊断市场：影像检查细分（依检测类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • MRI（磁振造影）
  • CT（电脑断层扫描）扫描
  • 超音波
  • X射线

第七章 区域和国家分析

  • 全球罕见疾病诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球罕见疾病诊断市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 罕见疾病诊断市场：竞争格局
  • 罕见疾病诊断市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Sanofi Genzyme
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • BioMarin Pharmaceutical Inc.
  • OPKO Health Inc.
  • Sarepta Therapeutics Inc.
  • Natera Inc.
  • Invitae Corporation
  • Ultragenyx Pharmaceutical Inc.
  • Travere Therapeutics Inc.
  • BGI Genomics Co. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年罕见疾病诊断市场：提供新机会的国家
  • 2029年罕见疾病诊断市场：细分市场带来新机会
  • 2029年罕见疾病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25251u

Rare disease diagnostics involves the identification and diagnosis of medical conditions that are considered rare or uncommon. These diagnostics play a crucial role in early detection and diagnosis, aiding in the selection of targeted and personalized treatment plans for uncommon disorders.

The primary tests included in rare disease diagnostics are genetic tests, general lab tests, and imaging tests. Genetic tests are laboratory procedures that examine chromosomes, genes, or gene expression in human cells or tissue. Various technologies, including capillary sequencing, whole genome sequencing, whole exome sequencing, and microarrays, utilize different samples such as DNA samples, buccal swab samples, blood, and saliva for the diagnosis of various diseases. These diseases include gastroenterology diseases, endocrine and metabolism disorders, hematology and oncology diseases, dermatology diseases, cardiovascular disorders, and neurology diseases. Rare disease diagnostics are employed by various end-users, including hospital laboratories, diagnostics laboratories, genetic testing laboratories, and cancer research laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The rare disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides rare disease diagnostics market statistics, including rare disease diagnostics industry global market size, regional shares, competitors with a rare disease diagnostics market share, detailed rare disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease diagnostics industry. This rare disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rare disease diagnostics market size has grown strongly in recent years. It will grow from $35.23 billion in 2024 to $38.14 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the rise in demand for cloud-based diagnostics, increased focus on improving efficiency, increased prevalence of neurological disease, increased immunological disorders, increased healthcare spending.

The rare disease diagnostics market size is expected to see rapid growth in the next few years. It will grow to $56.08 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing prevalence of rare diseases, increasing government initiatives, increasing number of hospitals and diagnostic laboratories, growing hematology diseases, increasing healthcare infrastructure. Major trends in the forecast period include advancements in genetic testing technologies, introduction of whole-genome sequencing and next-generation sequencing (NGS), extensive investments, strategic collaborations for research initiatives.

The forecast of 10.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. providers by driving up the cost of next-generation sequencing panels and CRISPR-based detection kits sourced from the UK and South Korea, exacerbating diagnostic delays and raising genetic testing expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rare disease diagnostics market is poised for growth, driven by the increasing incidence of rare diseases. Rare diseases, characterized by their low prevalence in the population, necessitate specialized diagnostics for effective management, identification of potential therapeutics, and avoidance of unnecessary treatments. For instance, data from the International Osteoporosis Foundation (IOF) in February 2021 highlighted that over 300 million people worldwide suffer from rare diseases, affecting 3.5% to 5.9% of the global population. Additionally, Health Match reported in November 2022 that there are approximately 150 rare kidney ailments with a prevalence of 60-80 incidences per 100,000 people in America and Europe. Hence, the rising incidence of rare diseases is a driving force for the growth of the rare disease diagnostics market.

The growing aging population is another factor propelling the expansion of the rare disease diagnostics market. With an aging population, there is an increased need for early identification and personalized treatment approaches facilitated by rare disease diagnostics. According to The United States Census Bureau's June 2023 report, the median age in the United States rose to 38.9 years in 2022, indicating a continuous aging trend in the population. This demographic shift is contributing to the growth of the rare disease diagnostics market by improving the overall management of health conditions in the elderly.

Advancements in technology have become a prominent trend in the rare disease diagnostics market, with major companies adopting new technologies to sustain their market position. For example, in April 2023, Centogene GmbH introduced CentoGenome, a whole genome sequencing solution designed for diagnosing rare and neurodegenerative diseases. This advanced next-generation sequencing (NGS)-based assay covers a wide range of disease-causing variants, offering a comprehensive approach to rare disease diagnostics.

Major companies in the rare disease diagnostics market are also focusing on developing innovative products, such as genetic testing, to enhance their market share. Genetic testing for rare cancers involves using advanced genetic analysis techniques to identify and understand genetic components associated with these diseases. Illumina, a biotechnology company, launched the TruSight Oncology Comprehensive test kit in March 2022, which analyzes 517 cancer-related genes across nearly 30 solid tumor types in a single tissue sample.

In April 2022, Sema4 Holding Corp., a patient-centered health intelligence company, acquired GeneDx for $623 million. This strategic acquisition is expected to bolster Sema4's AI-driven genomic and clinical data analytics platform. GeneDx is a genomic testing service provider specializing in the diagnosis of rare and ultra-rare pediatric genetic illnesses.

Major companies operating in the rare disease diagnostics market include Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Astellas Pharma Inc., Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BioMarin Pharmaceutical Inc., OPKO Health Inc., Sarepta Therapeutics Inc., Natera Inc., Invitae Corporation, Ultragenyx Pharmaceutical Inc., Travere Therapeutics Inc., BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., Agios Pharmaceuticals Inc., Orphazyme A/S, RareCyte Inc.

North America was the largest region in the rare disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the rare disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The rare disease diagnostics market consists of revenues earned by entities by providing services such as clinical evaluation, parallel sequencing, targeted sequencing, laboratory testing, and specialist consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare disease diagnostics market also includes sales of vision evaluation instruments, blood pressure cuffs, cardiac monitors, and advanced imaging equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Genetic Test; General Lab Test; Imaging Test
  • 2) By Technology: Capillary Sequencing; Whole Genome Sequencing; Whole Exome Sequencing; Microarrays
  • 3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample; Buccal Swab Sample; Blood; Saliva
  • 4) By Disease Type: Gastroenterology Disease; Endocrine And Metabolism Disorders Disease; Hematology And Oncology Disease; Dermatology Disease; Cardiovascular Disorders; Neurology Disease
  • 5) By End User: Hospital Laboratories; Diagnostics Laboratories; Genetic Testing Laboratories; Cancer Research Laboratories
  • Subsegments:
  • 1) By Genetic Test: Whole Genome Sequencing; Targeted Gene Panels; Exome Sequencing; Carrier Testing
  • 2) By General Lab Test: Blood Tests; Biochemical Assays; Urine Tests; Cytogenetic Tests
  • 3) By Imaging Test: MRI (Magnetic Resonance Imaging); CT (Computed Tomography) Scans; Ultrasound; X-Rays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Astellas Pharma Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; PerkinElmer Inc.; Sanofi Genzyme; Illumina Inc.; Bio-Rad Laboratories Inc.; Qiagen NV; BioMarin Pharmaceutical Inc.; OPKO Health Inc.; Sarepta Therapeutics Inc.; Natera Inc.; Invitae Corporation; Ultragenyx Pharmaceutical Inc.; Travere Therapeutics Inc.; BGI Genomics Co. Ltd.; 23andMe Holding Co.; Ambry Genetics Corporation; Centogene N.V.; GENEWIZ Inc.; Blueprint Genetics Inc.; Oxford Gene Technology Limited; Strand Life Sciences Pvt. Ltd.; Agios Pharmaceuticals Inc.; Orphazyme A/S; RareCyte Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rare Disease Diagnostics Market Characteristics

3. Rare Disease Diagnostics Market Trends And Strategies

4. Rare Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rare Disease Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Rare Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Rare Disease Diagnostics Market Growth Rate Analysis
  • 5.4. Global Rare Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Rare Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Rare Disease Diagnostics Total Addressable Market (TAM)

6. Rare Disease Diagnostics Market Segmentation

  • 6.1. Global Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Test
  • General Lab Test
  • Imaging Test
  • 6.2. Global Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Capillary Sequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Microarrays
  • 6.3. Global Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Sample
  • Buccal Swab Sample
  • Blood
  • Saliva
  • 6.4. Global Rare Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gastroenterology Disease
  • Endocrine And Metabolism Disorders Disease
  • Hematology And Oncology Disease
  • Dermatology Disease
  • Cardiovascular Disorders
  • Neurology Disease
  • 6.5. Global Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Laboratories
  • Diagnostics Laboratories
  • Genetic Testing Laboratories
  • Cancer Research Laboratories
  • 6.6. Global Rare Disease Diagnostics Market, Sub-Segmentation Of Genetic Test, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Sequencing
  • Targeted Gene Panels
  • Exome Sequencing
  • Carrier Testing
  • 6.7. Global Rare Disease Diagnostics Market, Sub-Segmentation Of General Lab Test, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Biochemical Assays
  • Urine Tests
  • Cytogenetic Tests
  • 6.8. Global Rare Disease Diagnostics Market, Sub-Segmentation Of Imaging Test, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MRI (Magnetic Resonance Imaging)
  • CT (Computed Tomography) Scans
  • Ultrasound
  • X-Rays

7. Rare Disease Diagnostics Market Regional And Country Analysis

  • 7.1. Global Rare Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Rare Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rare Disease Diagnostics Market

  • 8.1. Asia-Pacific Rare Disease Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rare Disease Diagnostics Market

  • 9.1. China Rare Disease Diagnostics Market Overview
  • 9.2. China Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rare Disease Diagnostics Market

  • 10.1. India Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rare Disease Diagnostics Market

  • 11.1. Japan Rare Disease Diagnostics Market Overview
  • 11.2. Japan Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rare Disease Diagnostics Market

  • 12.1. Australia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rare Disease Diagnostics Market

  • 13.1. Indonesia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rare Disease Diagnostics Market

  • 14.1. South Korea Rare Disease Diagnostics Market Overview
  • 14.2. South Korea Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rare Disease Diagnostics Market

  • 15.1. Western Europe Rare Disease Diagnostics Market Overview
  • 15.2. Western Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rare Disease Diagnostics Market

  • 16.1. UK Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rare Disease Diagnostics Market

  • 17.1. Germany Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rare Disease Diagnostics Market

  • 18.1. France Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rare Disease Diagnostics Market

  • 19.1. Italy Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rare Disease Diagnostics Market

  • 20.1. Spain Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rare Disease Diagnostics Market

  • 21.1. Eastern Europe Rare Disease Diagnostics Market Overview
  • 21.2. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rare Disease Diagnostics Market

  • 22.1. Russia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rare Disease Diagnostics Market

  • 23.1. North America Rare Disease Diagnostics Market Overview
  • 23.2. North America Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rare Disease Diagnostics Market

  • 24.1. USA Rare Disease Diagnostics Market Overview
  • 24.2. USA Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rare Disease Diagnostics Market

  • 25.1. Canada Rare Disease Diagnostics Market Overview
  • 25.2. Canada Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rare Disease Diagnostics Market

  • 26.1. South America Rare Disease Diagnostics Market Overview
  • 26.2. South America Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rare Disease Diagnostics Market

  • 27.1. Brazil Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rare Disease Diagnostics Market

  • 28.1. Middle East Rare Disease Diagnostics Market Overview
  • 28.2. Middle East Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rare Disease Diagnostics Market

  • 29.1. Africa Rare Disease Diagnostics Market Overview
  • 29.2. Africa Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rare Disease Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Rare Disease Diagnostics Market Competitive Landscape
  • 30.2. Rare Disease Diagnostics Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Rare Disease Diagnostics Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Sanofi Genzyme
  • 31.5. Illumina Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. Qiagen NV
  • 31.8. BioMarin Pharmaceutical Inc.
  • 31.9. OPKO Health Inc.
  • 31.10. Sarepta Therapeutics Inc.
  • 31.11. Natera Inc.
  • 31.12. Invitae Corporation
  • 31.13. Ultragenyx Pharmaceutical Inc.
  • 31.14. Travere Therapeutics Inc.
  • 31.15. BGI Genomics Co. Ltd.

32. Global Rare Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rare Disease Diagnostics Market

34. Recent Developments In The Rare Disease Diagnostics Market

35. Rare Disease Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Rare Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Rare Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Rare Disease Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer